COVID-19 | Orchestra

Persistent symptoms after 1 year in hospitalized children with COVID-19, compared to controls

2023

Authors: Conde M, Gastesi I, de Pablo L, Villanueva S, Aguilera-Alonso D, Esteban A, Epalza C, López M, Domínguez S, Gómez P, Ballesteros A, Pinto C, Navarro M, Giaquinto C, Moraleda C, Tagarro A, on behalf of EPICO-AEP and ORCHESTRA Working Group

Presented at: ESPID 2023

View poster

Risk Factors for Severe Acute SARS-CoV-2 Disease in Pediatric Population

2023

Authors: Tagarro A, Gastesi I, Villanueva S, Ramírez A, Mesa ML, Vasquez P, Friedrich G, Naranjo M, Restrepo S, Baquero OL, Mejía LM, Álvarez C, Leoz I, Calvo C, Epalza C, Soriano-Arandes A, Menasalvas A, Navarro M, Herranz M, Fumadó V, Crichton S, Le Prevost M, Giaquinto C, Reinos T, Conde M, Moraleda C, on behalf of EPICO-AEP, EPICO-Colombia and ORCHESTRA Working Groups

Presented at: ESPID 2023

View poster

The Estimation of Long-COVID Prevalence and Long-Term Persistence in Italian Children After COVID-19 Compared to Un-Infected Subjects: An Analysis Using a Pediatric Primary Care Database

2023

Authors: Di Chiara C, Barbieri E, Chen YX, Visonà E, Cavagnis S, Sturniolo G, Parca A, Liberati C, Cantarutti L, Lupattelli A, Le Prevost M, Corrao G, Giaquinto C.

Presented at: ESPID 2023

View poster

Persistent symptoms in children admitted with COVID similar to controls 1 year later

2023

Authors: Tagarro A, Villanueva S, Esteban A, López M, Conde M, de Pablo L, Aguilera-Alonso D, Gastesi I, Domínguez S, Epalza C, Ballesteros A, Pinto C, Giaquinto C, Moraleda C, on behalf of EPICO and ORCHESTRA Working Group

Presented at: CROI 2023

Read more

Comorbidities that increase risk for severe acute COVID-19 in pediatric population

2023

Authors: García TA, García GI, Medina VS, Varela RA, Rubio MLM, Hoyos VP, Friedrich G, Vanegas NM, Gualteros RS, Vaquero LO, Mejía ML, Álvarez C, Gordillo LI, Rey CC, Errondo EC, Arandes ST, Ruiz MA, Gómez NM, Aguirre HM, Pérez FV, le Prevost M, Giaquinto C, Redecilla MC

Presented at: CROI 2023

Read more

Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild COVID-19 in Children

2022

Authors: C. D. Chiara, S. Carraro, S. Zanconato, S. Cozzani, E. Baraldi et al.

Published in: National Library of Medicine

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease

2022

Authors: L. Bosa, C. Di Chiara, P. Gaio, C. Cosma, A. Padoan et al.

Published in: Frontiers in Pediatrics

Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection

2021

Authors: D Sirico, CD Chiara, P Costenaro, F Bonfante, S Cozzani, M Plebani, E Reffo, B Castaldi, D Dona, LD Dalt, C Giaquinto, and GD Salvo

Published in: European Heart Journal

 

Abstract

Aims Compared with adult patients, clinical manifestations of children’s coronavirus disease-2019 (COVID-19) are generally perceived as less severe.

Mild SARS-CoV-2 infections and neutralizing antibody titers

2021

Authors: F Bonfante, P Costenaro, A Cantarutti, CD Chiara, A Bortolami, MR Petrara, F Carmona, M Pagliari, C Cosma, S Cozzani, E Mazzetto, GD Salvo, LD Dalt, P Palma, L Barzon, G Corrao, C Terregino, A Padoan, M Plebani, AD Rossi, D Donà, C Giaquinto

Published in: Pediatrics

 

Abstract

Background. Recent evidence suggests that neutralizing antibodies to SARS-CoV-2 may persist over time;

1